We are live on ! Find out more
MFA

Mayflower Financial Advisors Portfolio holdings

AUM $1.16B
1-Year Est. Return 24.36%
This Fund
S&P 500
This Quarter Est. Return
-11.04%
1 Year Est. Return
+24.36%
3 Year Est. Return
+68.75%
5 Year Est. Return
+72.53%
10 Year Est. Return
AUM
$653M
AUM Growth
-$90.3M
Cap. Flow
-$515M
Cap. Flow %
-78.91%
Top 10 Hldgs %
34.46%
Holding
376
New
13
Increased
149
Reduced
138
Closed
40

Sector Composition

Rank Sector Weight
1 Healthcare 9.03%
2 Technology 8.59%
3 Utilities 7.88%
4 Consumer Staples 7.87%
5 Consumer Discretionary 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTA icon
301
Ulta Beauty
ULTA
$23.2B
$209K 0.03%
541
-5
-0.9% -$1.99K
NEAR icon
302
iShares Short Maturity Bond ETF
NEAR
$4.85B
$207K 0.03%
4,199
-530
-11% -$26.2K
ISRG icon
303
Intuitive Surgical
ISRG
$132B
$204K 0.03%
1,015
-43
-4% -$10.1K
QCOM icon
304
Qualcomm
QCOM
$168B
$202K 0.03%
1,584
+93
+6% +$12.6K
ADI icon
305
Analog Devices
ADI
$184B
$201K 0.03%
1,377
+124
+10% +$19.5K
KMI icon
306
Kinder Morgan
KMI
$69.7B
$200K 0.03%
11,958
-89
-0.7% -$1.67K
ET icon
307
Energy Transfer Partners
ET
$71.2B
$189K 0.03%
18,901
-1,113
-6% -$12.5K
BRKL
308
DELISTED
Brookline Bancorp
BRKL
$154K 0.02%
11,567
SPH icon
309
Suburban Propane Partners
SPH
$1.18B
$153K 0.02%
10,000
SLQT icon
310
SelectQuote
SLQT
$120M
$136K 0.02%
54,911
NLY icon
311
Annaly Capital Management
NLY
$17.1B
$123K 0.02%
5,193
-51
-1% -$1.32K
SAND
312
DELISTED
Sandstorm Gold
SAND
$118K 0.02%
19,770
LILAK icon
313
Liberty Latin America Class C
LILAK
$1.72B
$79K 0.01%
11,167
ESGD icon
314
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.2B
$66K 0.01%
13,221
-20
-0.2% -$1.36K
INO icon
315
Inovio Pharmaceuticals
INO
$69.6M
$54K 0.01%
2,579
VAPO
316
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$41K 0.01%
2,050
+694
+51% +$25.4K
VKTX icon
317
Viking Therapeutics
VKTX
$3.88B
$39K 0.01%
13,485
REAL icon
318
The RealReal
REAL
$1.54B
$38K 0.01%
15,115
+94
+0.6% +$418
CFRX
319
DELISTED
ContraFect Corporation
CFRX
$31K ﹤0.01%
125
CRSP icon
320
CRISPR Therapeutics
CRSP
$4.99B
$28K ﹤0.01%
12,636
-342
-3% -$20.1K
REVB icon
321
Revelation Biosciences
REVB
$4.38M
0
NGL icon
322
NGL Energy Partners
NGL
$2.17B
$16K ﹤0.01%
10,728
XFOR icon
323
X4 Pharmaceuticals
XFOR
$393M
$10K ﹤0.01%
333
AVTX icon
324
Avalo Therapeutics
AVTX
$989M
$5K ﹤0.01%
3
AMPE
325
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$4K ﹤0.01%
80

Similar funds

Mayflower Financial Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Mayflower Financial Advisors held 376 positions worth $653M, down 12% from $743M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Mayflower Financial Advisors withdrew a net $515M in Q2 2022, closing 40 positions and reducing 138 holdings. Its most notable exit was Digital Realty Trust, an estimated $662K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, up from 8.3% a quarter earlier, followed by Technology and Utilities.

Against the trend, Mayflower Financial Advisors opened a new position in Invesco S&P Emerging Markets Low Volatility ETF worth $1.62M.

  • Mayflower Financial Advisors's largest Q2 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 69,511 shares worth $1.62M.
  • Mayflower Financial Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2022, an estimated $4.59M increase.
  • Mayflower Financial Advisors's biggest Q2 2022 reduction was Amazon, cutting an estimated $520M.
  • Mayflower Financial Advisors fully exited Digital Realty Trust in Q2 2022, selling an estimated $662K.
  • Mayflower Financial Advisors's ten largest holdings make up 34% of its $653M portfolio in Q2 2022.
  • Mayflower Financial Advisors opened 13 new positions and closed 40 in Q2 2022.
  • Mayflower Financial Advisors's portfolio value fell 12% quarter-over-quarter to $653M.

Based on Mayflower Financial Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.